Feb 6 (Reuters) - AstraZeneca ( AZN ) said on Thursday

it has received a notice in China over unpaid taxes related to

the import of two cancer therapies, as the drugmaker continues

to gauge the impact of probes into certain executives and

activities in the key market.

Last December, AstraZeneca ( AZN ) named Iskra Reic as its new

international executive vice president, who took over from Leon

Wang in its efforts to stabilise its operations in China, after

Wang was detained by Chinese authorities in October.

A fine of between one and five times the unpaid tax amount

of $0.9 million may be levied if the company is found liable,

AstraZeneca ( AZN ) said in its fourth-quarter earnings statement, where

it also forecast 2025 sales above analyst expectations.